SIMILAR PATTERNS OF AMINO ACIDS FOR 6GBN_C_ADNC501_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ac5 | KEX1(DELTA)P (Saccharomycescerevisiae) |
PF00450(Peptidase_S10) | 5 | HIS A 150ASP A 141LEU A 49LEU A 36PHE A 185 | None | 1.21A | 6gbnC-1ac5A:4.3 | 6gbnC-1ac5A:21.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1aua | PHOSPHATIDYLINOSITOLTRANSFER PROTEINSEC14P (Saccharomycescerevisiae) |
PF00650(CRAL_TRIO)PF03765(CRAL_TRIO_N) | 5 | THR A 25ASP A 20LYS A 116ASP A 117LEU A 22 | None | 1.28A | 6gbnC-1auaA:undetectable | 6gbnC-1auaA:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fb5 | ORNITHINETRANSCARBAMOYLASE (Ovis aries) |
PF00185(OTCace)PF02729(OTCace_N) | 5 | LEU A 59THR A 343ASP A 62LEU A 74LEU A 76 | None | 1.45A | 6gbnC-1fb5A:5.0 | 6gbnC-1fb5A:20.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1g7r | TRANSLATIONINITIATION FACTORIF2/EIF5B (Methanothermobacterthermautotrophicus) |
PF00009(GTP_EFTU)PF03144(GTP_EFTU_D2)PF11987(IF-2)PF14578(GTP_EFTU_D4) | 5 | LEU A 161ASP A 162ASP A 183MET A 147PHE A 146 | None | 1.22A | 6gbnC-1g7rA:3.5 | 6gbnC-1g7rA:23.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tj7 | ARGININOSUCCINATELYASE (Escherichiacoli) |
PF00206(Lyase_1)PF14698(ASL_C2) | 5 | LEU A 103HIS A 104ASP A 33LEU A 3HIS A 85 | None | 1.41A | 6gbnC-1tj7A:undetectable | 6gbnC-1tj7A:23.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 53HIS A 54THR A 56ASP A 134GLU A 200LYS A 230ASP A 234LEU A 389LEU A 392HIS A 398MET A 403PHE A 407 | NoneADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-3.1A)ADN A 502 (-4.0A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)NAD A 501 ( 3.8A)ADN A 502 ( 4.9A)ADN A 502 ( 3.5A)ADN A 502 (-3.6A)None | 0.27A | 6gbnC-1v8bA:54.8 | 6gbnC-1v8bA:49.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1vma | CELL DIVISIONPROTEIN FTSY (Thermotogamaritima) |
PF00448(SRP54)PF02881(SRP54_N) | 5 | LEU A 79THR A 256LEU A 292LEU A 291PHE A 282 | None | 1.50A | 6gbnC-1vmaA:undetectable | 6gbnC-1vmaA:22.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2bb0 | IMIDAZOLONEPROPIONASE (Bacillussubtilis) |
PF01979(Amidohydro_1) | 5 | LEU A 103GLU A 223LEU A 301HIS A 272PHE A 221 | None | 1.33A | 6gbnC-2bb0A:undetectable | 6gbnC-2bb0A:24.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2eu9 | DUAL SPECIFICITYPROTEIN KINASE CLK3 (Homo sapiens) |
PF00069(Pkinase) | 5 | LEU A 205GLU A 201ASP A 320LEU A 274PHE A 236 | None | 1.46A | 6gbnC-2eu9A:undetectable | 6gbnC-2eu9A:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2huo | INOSITOL OXYGENASE (Mus musculus) |
PF05153(MIOX) | 5 | ASP A 88LYS A 127ASP A 124LEU A 254HIS A 123 | INS A 303 (-3.7A)INS A 303 (-2.6A) FE A 302 ( 2.5A)None FE A 301 ( 3.2A) | 1.43A | 6gbnC-2huoA:undetectable | 6gbnC-2huoA:19.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ml8 | FATTY ACID SYNTHASESUBUNIT ALPHA (Saccharomycescerevisiae) |
no annotation | 5 | LEU A 187THR A 197GLU A 202LEU A 206LEU A 209 | None | 1.19A | 6gbnC-2ml8A:undetectable | 6gbnC-2ml8A:17.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2pqd | 3-PHOSPHOSHIKIMATE1-CARBOXYVINYLTRANSFERASE (Agrobacteriumsp.) |
PF00275(EPSP_synthase) | 5 | THR A 275ASP A 300GLU A 299LYS A 205ASP A 201 | None | 1.40A | 6gbnC-2pqdA:undetectable | 6gbnC-2pqdA:21.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2waa | XYLAN ESTERASE,PUTATIVE, AXE2C (Cellvibriojaponicus) |
PF13472(Lipase_GDSL_2) | 5 | LEU A 125THR A 122GLU A 96LEU A 52LEU A 119 | None | 1.39A | 6gbnC-2waaA:5.8 | 6gbnC-2waaA:21.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | ASP A 156GLU A 218LYS A 248ASP A 252LEU A 407 | ADN A 500 (-2.9A)ADN A 500 (-2.6A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)NAD A 550 (-4.2A) | 1.15A | 6gbnC-3ce6A:55.7 | 6gbnC-3ce6A:54.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 68HIS A 69THR A 71ASP A 156GLU A 218LYS A 248ASP A 252LEU A 407LEU A 410HIS A 416MET A 421PHE A 425 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-2.9A)ADN A 500 (-2.6A)ADN A 500 (-2.8A)ADN A 500 (-2.7A)NAD A 550 (-4.2A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A)ADN A 500 (-4.8A) | 0.59A | 6gbnC-3ce6A:55.7 | 6gbnC-3ce6A:54.23 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 51ASP A 130GLU A 155LEU A 343HIS A 352 | NoneADN A 438 (-4.1A)ADN A 438 (-3.8A)NAD A 439 ( 4.0A)ADN A 438 ( 3.6A) | 1.35A | 6gbnC-3g1uA:60.1 | 6gbnC-3g1uA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 51HIS A 52THR A 54ASP A 130GLU A 155LEU A 343LEU A 346HIS A 352MET A 357PHE A 361 | NoneADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-4.1A)ADN A 438 (-3.8A)NAD A 439 ( 4.0A)ADN A 438 ( 4.8A)ADN A 438 ( 3.6A)ADN A 438 (-3.7A)None | 0.56A | 6gbnC-3g1uA:60.1 | 6gbnC-3g1uA:63.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62ASP A 139LYS A 229ASP A 233LEU A 388 | RAB A 602 (-3.8A)RAB A 602 (-3.0A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 ( 4.7A) | 1.39A | 6gbnC-3glqA:58.4 | 6gbnC-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 67ASP A 139ASP A 233MET A 399 | RAB A 602 (-3.8A)RAB A 602 (-4.5A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)RAB A 602 (-3.6A) | 1.39A | 6gbnC-3glqA:58.4 | 6gbnC-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 61ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385HIS A 394 | NoneRAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)NAD A 601 ( 3.6A) | 1.26A | 6gbnC-3glqA:58.4 | 6gbnC-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 199LYS A 229ASP A 233LEU A 385LEU A 388HIS A 394MET A 399PHE A 403 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.0A)RAB A 602 (-4.6A)RAB A 602 (-3.0A)RAB A 602 (-2.5A)NAD A 601 ( 4.1A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A)None | 0.39A | 6gbnC-3glqA:58.4 | 6gbnC-3glqA:59.21 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 52ASP A 130GLU A 155LYS A 185ASP A 189LEU A 343HIS A 352 | ADN A 439 ( 4.7A)NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)NAD A 438 (-4.0A)ADN A 439 ( 3.3A) | 1.44A | 6gbnC-3h9uA:62.1 | 6gbnC-3h9uA:65.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 51HIS A 52THR A 54ASP A 130GLU A 155LYS A 185ASP A 189LEU A 343LEU A 346HIS A 352MET A 357PHE A 361 | NoneADN A 439 ( 4.7A)ADN A 439 (-2.7A)NoneNoneNAD A 438 ( 3.9A)NAD A 438 ( 4.4A)NAD A 438 (-4.0A)ADN A 439 ( 4.7A)ADN A 439 ( 3.3A)ADN A 439 ( 3.7A)None | 0.18A | 6gbnC-3h9uA:62.1 | 6gbnC-3h9uA:65.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3htv | D-ALLOSE KINASE (Escherichiacoli) |
PF00480(ROK) | 5 | LEU A 98LEU A 106LEU A 67MET A 13PHE A 71 | None | 1.49A | 6gbnC-3htvA:undetectable | 6gbnC-3htvA:20.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 54HIS A 55ASP A 132GLU A 192LYS A 222ASP A 226LEU A 378HIS A 387 | NoneADN A 500 (-4.0A)ADN A 500 (-3.3A)ADN A 500 (-3.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)NAD A 550 (-4.3A)ADN A 500 (-3.4A) | 1.31A | 6gbnC-3n58A:59.3 | 6gbnC-3n58A:60.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 54HIS A 55THR A 57ASP A 132GLU A 192LYS A 222ASP A 226LEU A 378LEU A 381HIS A 387MET A 392PHE A 396 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.3A)ADN A 500 (-3.6A)ADN A 500 (-2.7A)ADN A 500 ( 2.6A)NAD A 550 (-4.3A)ADN A 500 ( 4.8A)ADN A 500 (-3.4A)ADN A 500 (-3.7A)None | 0.27A | 6gbnC-3n58A:59.3 | 6gbnC-3n58A:60.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 62ASP A 139GLU A 205LYS A 235ASP A 239LEU A 395HIS A 404 | ADE A 506 (-4.6A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)NAD A 501 (-4.2A)ADE A 506 (-3.4A) | 1.44A | 6gbnC-3oneA:55.4 | 6gbnC-3oneA:58.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 61HIS A 62ASP A 139GLU A 205LYS A 235ASP A 239LEU A 398 | NoneADE A 506 (-4.6A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)ADE A 506 ( 4.7A) | 1.34A | 6gbnC-3oneA:55.4 | 6gbnC-3oneA:58.49 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 61HIS A 62THR A 64ASP A 139GLU A 205LYS A 235ASP A 239LEU A 395LEU A 398HIS A 404MET A 409PHE A 413 | NoneADE A 506 (-4.6A)ADE A 506 (-2.8A)NoneNoneNAD A 501 ( 4.2A)NAD A 501 ( 4.5A)NAD A 501 (-4.2A)ADE A 506 ( 4.7A)ADE A 506 (-3.4A)ADE A 506 (-3.8A)ADE A 506 (-4.9A) | 0.51A | 6gbnC-3oneA:55.4 | 6gbnC-3oneA:58.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3pf7 | BENZOYL-COAOXYGENASE COMPONENTB (Azoarcusevansii) |
no annotation | 5 | LEU A 427HIS A 423LYS A 398HIS A 406PHE A 395 | None | 0.91A | 6gbnC-3pf7A:undetectable | 6gbnC-3pf7A:24.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3zdu | CYCLIN-DEPENDENTKINASE-LIKE 3 (Homo sapiens) |
PF00069(Pkinase) | 5 | LEU A 54GLU A 50ASP A 143LEU A 116PHE A 79 | None38R A 350 ( 4.8A) NA A 353 ( 2.5A)None38R A 350 (-4.1A) | 1.44A | 6gbnC-3zduA:undetectable | 6gbnC-3zduA:21.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4kc8 | GLYCOSIDE HYDROLASE,FAMILY 43 (Thermotogapetrophila) |
PF04616(Glyco_hydro_43)PF16369(GH43_C) | 5 | LEU A 440THR A 455GLU A 366HIS A 346PHE A 349 | None | 1.22A | 6gbnC-4kc8A:undetectable | 6gbnC-4kc8A:22.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 58ASP A 135GLU A 197LYS A 227ASP A 231LEU A 383HIS A 392 | ADN A 501 (-4.0A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)NAD A 503 ( 3.9A)ADN A 501 (-3.5A) | 1.47A | 6gbnC-4lvcA:58.5 | 6gbnC-4lvcA:60.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 57HIS A 58THR A 60ASP A 135GLU A 197LYS A 227ASP A 231LEU A 383LEU A 386HIS A 392MET A 397PHE A 401 | NoneADN A 501 (-4.0A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-3.6A)ADN A 501 (-2.7A)ADN A 501 (-3.1A)NAD A 503 ( 3.9A)ADN A 501 ( 4.7A)ADN A 501 (-3.5A)ADN A 501 (-3.7A)ADN A 501 (-4.8A) | 0.23A | 6gbnC-4lvcA:58.5 | 6gbnC-4lvcA:60.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cr9 | ABC-TYPEFE3+-HYDROXAMATETRANSPORT SYSTEM,PERIPLASMICCOMPONENT (Saccharomonosporaviridis) |
PF01497(Peripla_BP_2) | 5 | LEU A 180ASP A 130LEU A 63LEU A 133PHE A 54 | None | 1.12A | 6gbnC-5cr9A:undetectable | 6gbnC-5cr9A:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ep1 | PUTATIVE REPRESSORPROTEIN LUXO (Photobacteriumangustum) |
PF00158(Sigma54_activat) | 5 | GLU A 177ASP A 241LEU A 310MET A 239PHE A 194 | None | 1.48A | 6gbnC-5ep1A:undetectable | 6gbnC-5ep1A:22.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hif | RECONSTRUCTEDLACTONASE ANCESTOR,ANC1-MPH (syntheticconstruct) |
PF00753(Lactamase_B) | 5 | HIS A 204THR A 201ASP A 79LEU A 222HIS A 119 | NoneNoneNoneNone ZN A 401 (-3.3A) | 1.39A | 6gbnC-5hifA:undetectable | 6gbnC-5hifA:21.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ks8 | PYRUVATE CARBOXYLASESUBUNIT BETA (Methylobacillusflagellatus) |
PF00364(Biotin_lipoyl)PF00682(HMGL-like)PF02436(PYC_OADA) | 5 | LEU C 81THR C 142GLU C 44ASP C 227HIS C 201 | PYR C2001 (-4.7A)NoneNoneNoneNone | 1.27A | 6gbnC-5ks8C:undetectable | 6gbnC-5ks8C:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5l94 | CYTOCHROME P450 (Bacillusmegaterium) |
PF00067(p450) | 5 | LEU A 283THR A 247GLU A 280LEU A 366PHE A 345 | NoneHEM A 501 ( 4.3A)NoneNoneHEM A 501 (-4.5A) | 1.48A | 6gbnC-5l94A:undetectable | 6gbnC-5l94A:19.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5na2 | CAPSID PROTEIN (P24) (Felineimmunodeficiencyvirus) |
no annotation | 5 | LEU A 129LEU A 75LEU A 72MET A 51PHE A 39 | None | 1.44A | 6gbnC-5na2A:undetectable | 6gbnC-5na2A:19.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5oko | PHOSPHATIDYLINOSITOL3,4,5-TRISPHOSPHATE5-PHOSPHATASE 2 (Homo sapiens) |
PF03372(Exo_endo_phos) | 5 | LEU A 823LEU A 774LEU A 806MET A 870PHE A 852 | None | 1.48A | 6gbnC-5okoA:undetectable | 6gbnC-5okoA:20.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5tov | ADENOSYLHOMOCYSTEINASE (Thermotogamaritima) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 123THR A 124ASP A 113LEU A 156LEU A 150 | None | 1.16A | 6gbnC-5tovA:29.9 | 6gbnC-5tovA:41.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 53ASP A 137GLU A 211LYS A 241ASP A 245LEU A 401HIS A 410 | SAH A 502 (-4.0A)SAH A 502 (-3.4A)SAH A 502 (-3.8A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)NAD A 501 (-4.1A)SAH A 502 ( 3.5A) | 1.50A | 6gbnC-5utuA:52.9 | 6gbnC-5utuA:47.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 52HIS A 53THR A 55ASP A 137GLU A 211LYS A 241ASP A 245LEU A 401LEU A 404HIS A 410MET A 415PHE A 419 | NoneSAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-3.4A)SAH A 502 (-3.8A)SAH A 502 (-2.9A)SAH A 502 (-2.8A)NAD A 501 (-4.1A)SAH A 502 ( 4.7A)SAH A 502 ( 3.5A)SAH A 502 (-3.6A)SAH A 502 (-4.8A) | 0.27A | 6gbnC-5utuA:52.9 | 6gbnC-5utuA:47.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v1w | GLYCOSIDE HYDROLASE (Bacillushalodurans) |
PF03639(Glyco_hydro_81) | 5 | HIS A 716ASP A 363GLU A 720LYS A 740LEU A 681 | PO4 A 812 (-3.8A)NoneNoneNoneNone | 1.48A | 6gbnC-5v1wA:undetectable | 6gbnC-5v1wA:21.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | HIS A 59ASP A 136GLU A 197LYS A 227ASP A 231LEU A 386HIS A 395 | ADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 ( 3.4A) | 1.48A | 6gbnC-5v96A:56.7 | 6gbnC-5v96A:54.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 58HIS A 59THR A 61ASP A 136GLU A 197LYS A 227ASP A 231LEU A 386LEU A 389HIS A 395MET A 400PHE A 404 | NoneADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-2.9A)ADN A 502 (-3.5A)ADN A 502 (-2.9A)ADN A 502 (-2.8A)NAD A 501 (-3.9A)ADN A 502 ( 4.7A)ADN A 502 ( 3.4A)ADN A 502 (-3.8A)ADN A 502 (-4.9A) | 0.22A | 6gbnC-5v96A:56.7 | 6gbnC-5v96A:54.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vyw | PYRUVATE CARBOXYLASE (Lactococcuslactis) |
PF00289(Biotin_carb_N)PF00682(HMGL-like)PF02436(PYC_OADA)PF02785(Biotin_carb_C)PF02786(CPSase_L_D2) | 5 | LEU A 604THR A 665GLU A 567ASP A 756HIS A 730 | None | 1.34A | 6gbnC-5vywA:undetectable | 6gbnC-5vywA:17.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 54ASP A 131LYS A 186ASP A 190HIS A 353MET A 358PHE A 362 | NoneNoneNoneNAD A 501 (-4.1A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A)None | 0.89A | 6gbnC-5w4bA:52.9 | 6gbnC-5w4bA:65.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 54HIS A 55THR A 57ASP A 131GLU A 156LYS A 186ASP A 190MET A 358PHE A 362 | None9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNoneNoneNAD A 501 (-4.1A)9W4 A 502 (-3.6A)None | 0.78A | 6gbnC-5w4bA:52.9 | 6gbnC-5w4bA:65.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LYS A 186ASP A 190LEU A 344LEU A 347HIS A 353MET A 358 | NoneNAD A 501 (-4.1A)NAD A 501 (-4.0A)9W4 A 502 (-4.1A)NAD A 501 (-4.5A)9W4 A 502 (-3.6A) | 1.01A | 6gbnC-5w4bA:52.9 | 6gbnC-5w4bA:65.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LYS A 186ASP A 190LEU A 347HIS A 353PHE A 362 | NoneNAD A 501 (-4.1A)9W4 A 502 (-4.1A)NAD A 501 (-4.5A)None | 1.39A | 6gbnC-5w4bA:52.9 | 6gbnC-5w4bA:65.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5yq5 | OSTEOMODULIN (Homo sapiens) |
no annotation | 5 | LEU A 193LEU A 235LEU A 214MET A 182PHE A 156 | None | 1.26A | 6gbnC-5yq5A:undetectable | 6gbnC-5yq5A:11.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5z0u | NEOPULLULANASE 1 (Thermoactinomycesvulgaris) |
no annotation | 5 | LEU A 583THR A 496ASP A 609LEU A 537LEU A 541 | None | 1.06A | 6gbnC-5z0uA:undetectable | 6gbnC-5z0uA:13.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 58ASP A 136LYS A 191ASP A 195LEU A 352 | ADN A 501 (-3.9A)ADN A 501 (-3.0A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)ADN A 501 ( 4.8A) | 1.39A | 6gbnC-6aphA:66.5 | 6gbnC-6aphA:77.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57ASP A 136GLU A 161LYS A 191ASP A 195LEU A 349HIS A 358 | NoneADN A 501 (-3.0A)ADN A 501 (-2.5A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)NAD A 500 ( 4.3A)ADN A 501 ( 3.5A) | 1.39A | 6gbnC-6aphA:66.5 | 6gbnC-6aphA:77.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 12 | LEU A 57HIS A 58THR A 60ASP A 136GLU A 161LYS A 191ASP A 195LEU A 349LEU A 352HIS A 358MET A 363PHE A 367 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.0A)ADN A 501 (-2.5A)ADN A 501 (-2.8A)ADN A 501 (-2.7A)NAD A 500 ( 4.3A)ADN A 501 ( 4.8A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A)None | 0.58A | 6gbnC-6aphA:66.5 | 6gbnC-6aphA:77.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 7 | HIS B 61ASP B 139GLU B 164LYS B 194ASP B 198LEU B 373HIS B 382 | ADN B 502 ( 4.0A) ZN B 505 ( 2.5A)ADN B 502 (-3.6A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)NAD B 501 ( 3.9A)ADN B 502 (-3.4A) | 1.44A | 6gbnC-6f3mB:57.6 | 6gbnC-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 11 | HIS B 61THR B 63ASP B 139GLU B 164LYS B 194ASP B 198LEU B 373LEU B 376HIS B 382MET B 387PHE B 391 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) ZN B 505 ( 2.5A)ADN B 502 (-3.6A)ADN B 502 (-2.8A)ADN B 502 (-2.7A)NAD B 501 ( 3.9A)ADN B 502 ( 4.8A)ADN B 502 (-3.4A)ADN B 502 (-3.7A)ADN B 502 (-4.9A) | 0.28A | 6gbnC-6f3mB:57.6 | 6gbnC-6f3mB:undetectable |